Evidence map›Paper›PMID 33741696›Full record

ReviewDiabetes care2021

Resolving the Gestational Diabetes Diagnosis Conundrum: The Need for a Randomized Controlled Trial of Treatment.

Rudolf W Bilous, Paul B Jacklin, Michael J Maresh, David A Sacks

Abstract readReview
In one paragraph

Review in Diabetes care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Indicators from training healthcare providers on WHO-recommended best practices in prenatal care in Brazil: A before-and-after study.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Time to Move Beyond a Binary Criterion for Gestational Diabetes?Reproductive sciences (Thousand Oaks, Calif.) · 2024
    Review
  19. Exploring Structural Uncertainty in Cost-Effectiveness Modeling of Gestational Diabetes Screening: An Application Example from Norway.Medical decision making : an international journal of the Society for Medical Decision Making · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rudolf W BilousSchool of Medical Education, Newcastle University, Newcastle upon Tyne, U.K.
Paul B JacklinRoyal College of Obstetricians and Gynaecologists, London, U.K.
Michael J MareshDepartment of Obstetrics, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, U.K.
David A SacksDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA dasacks1@verizon.net.ORCID 0000-0003-3444-6476

Funding

Environmental and Social Health Determinants of Pregnancy Outcomes Related to COVID-19 PandemicR01ES030353 · NIEHS · UNIVERSITY OF CALIFORNIA-IRVINE · PI GETAHUN, DARIOS, WU, JUN · 2019 to 2022
$3.2M
NIEHS NIH HHS R01 ES030353
6 · The paper itself

Abstract

The diagnosis of and criteria for gestational diabetes mellitus (GDM) continue to divide the scientific and medical community, both between and within countries. Many argue for universal adoption of the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criteria and feel that further clinical trials are unjustified and even unethical. However, there are concerns about the large increase in number of women who would be diagnosed with GDM using these criteria and the subsequent impact on health care resources and the individual. This Perspective reviews the origins of the IADPSG consensus and points out some of its less well-known limitations, particularly with respect to identifying women at risk for an adverse pregnancy outcome. It also questions the clinical and cost-effectiveness data often cited to support the IADPSG glycemic thresholds. We present the argument that adoption of diagnostic criteria defining GDM should be based on response to treatment at different diagnostic thresholds of maternal glycemia. This will likely require an international multicenter trial of treatment.

Indexed as

Diabetes, GestationalPregnancy in DiabeticsBlood GlucoseFemaleGlucose Tolerance TestHumansMulticenter Studies as TopicPregnancyPregnancy OutcomeRandomized Controlled Trials as TopicBlood Glucose

Identifiers

PMID33741696
PMCPMC8578931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.